Insider Trading History of Wright Christopher I

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Wright Christopher I since 2021. This trader's CIK number is 1838503. At the time of last reporting, Wright Christopher I was the Director of Alkermes Plc.. (stock ticker symbol ALKS). Also see all insider trading activities at Alkermes Plc..

Note that in the past Wright Christopher I also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Cyclerion Therapeutics, Inc. (CYCN) by Wright Christopher I

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 CYCN 0 $0 2,637 $10,521 0 $0

Yearly summary of insider trading at Alkermes Plc. (ALKS) by Wright Christopher I

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ALKS 0 $0 0 $0 11,314 $0
2024 ALKS 0 $0 0 $0 9,405 $0
2023 ALKS 0 $0 0 $0 9,566 $0


Insider trading activities at 2 companies by Wright Christopher I:

1. Cyclerion Therapeutics, Inc. (CYCN)

2. Alkermes Plc. (ALKS)

Table 1. Insider trading of Cyclerion Therapeutics, Inc. (CYCN) by Wright Christopher I

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-02-25 CYCN Sale 2,637 3.99 10,521

Table 2. Insider trading of Alkermes Plc. (ALKS) by Wright Christopher I

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-06-08 ALKS Option Ex 3,301 .00 0
2025-05-31 ALKS Option Ex 8,013 .00 0
2024-06-29 ALKS Option Ex 6,104 .00 0
2024-06-08 ALKS Option Ex 3,301 .00 0
2023-07-07 ALKS Option Ex 5,957 .00 0
2023-06-08 ALKS Option Ex 3,609 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wright Christopher I (Director of Alkermes Plc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.